CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 42 enrolled
Drug / intervention
remifentanildrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01303627
NCT01303627Phase 4Completed
CompareCT.gov

The Effects of Maintenance a Remifentanil Infusion on the Hemodynamic Variables and Recovery Quality

Diskapi Teaching and Research Hospital·interventional·Posted Feb 25, 2011·Updated Jun 25, 2012

In Brief

A Phase 4 clinical trial evaluating remifentanil for Urinary Tract Problem. Completed, enrolled 42 participants across 1 site.

Detailed Summary

The effect of maintenance remifentanil infusion with target controlled infusion during laryngeal mask airway removal on hemodynamic parameters and emergence quality is going to be investigated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Tract Problem
CountriesTurkey (Türkiye)
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 25, 2011
Enrollment StartFeb 1, 2011
Primary CompletionMar 1, 2011
Study CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 15.4 years ago

Interventions

remifentanildrug

1-4 ng/mL i.v. infusion during the surgery, maintenance dosage till LMA removal is 1.5 ng/mL.